TMS for Autism Spectrum Disorder
(TMSinASD Trial)

Recruiting in Palo Alto (17 mi)

Age: 18 - 65

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Yale University

Approved in 3 jurisdictions

Trial Summary

What is the purpose of this trial?This trial will test if using magnetic pulses can improve social skills in adults with Autism Spectrum Disorder (ASD). The study will measure brain and behavior changes over time. Magnetic stimulation has been explored in various studies as a potential treatment for autism spectrum disorder (ASD), showing positive behavioral and brain activity results.

Eligibility Criteria

This trial is for individuals aged 18-40 with either typical development or a diagnosis of Autism Spectrum Disorder (ASD). They must be able to undergo EEG and eye-tracking tests. It's not suitable for those with serious brain issues, major psychiatric illnesses, medical conditions like stroke or seizures, recent drug/alcohol use, pregnant women, or anyone with metal in their body.

Inclusion Criteria

I am between 18 and 40 years old and either typically developing or have autism.

You are able to take part in a test that involves an EEG (a brain activity measurement) and eye-tracking.

Exclusion Criteria

Participants with major psychiatric illness that would preclude completion of study measures

You have consumed alcohol or used recreational drugs within the past day.

I am not pregnant nor suspect I might be.

+4 more

Participant Groups

The study is testing the impact of repetitive Transcranial Magnetic Stimulation (rTMS) on how people with ASD process social information. This involves looking at changes in brain activity and behavior before and after TMS using EEGs and eye-tracking technology.

2Treatment groups

Active Control

Placebo Group

Group I: Transcranial Magnetic Stimulation - realActive Control1 Intervention

Participants will receive active TMS during their study visit

Group II: Transcranial Magnetic Stimulation - shamPlacebo Group1 Intervention

Participants will receive sham stimulation during their study visit simulating TMS

TMS is already approved in United States, European Union, Canada for the following indications:

🇺🇸 Approved in United States as Transcranial Magnetic Stimulation for: